US Stock MarketDetailed Quotes
CKPT Checkpoint Therapeutics
- 2.100
- -0.050-2.33%
Close Sep 6 16:00 ET
- 2.140
- +0.040+1.90%
Post 20:02 ET
94.54MMarket Cap-1228P/E (TTM)
2.200High2.060Low389.36KVolume2.160Open2.150Pre Close821.47KTurnover1.11%Turnover RatioLossP/E (Static)45.02MShares3.62052wk High-6.00P/B73.37MFloat Cap1.30052wk Low--Dividend TTM34.94MShs Float105.000Historical High--Div YieldTTM6.51%Amplitude1.300Historical Low2.109Avg Price1Lot Size
Checkpoint Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -33.28%4.95M | 131.96%11.24M | -59.16%4.93M | -59.16%4.93M | -91.35%1.77M | -75.97%7.42M | -88.32%4.85M | -77.95%12.07M | -77.95%12.07M | -65.99%20.48M |
| -Cash and cash equivalents | -33.28%4.95M | 131.96%11.24M | -59.16%4.93M | -59.16%4.93M | -91.35%1.77M | -75.97%7.42M | -88.32%4.85M | -77.95%12.07M | -77.95%12.07M | -65.99%20.48M |
| Receivables | 32.26%41K | ---- | --0 | --0 | -35.42%31K | 72.22%31K | -32.69%35K | 329.41%73K | 329.41%73K | 65.52%48K |
| -Related party accounts receivable | 32.26%41K | ---- | --0 | --0 | -35.42%31K | 72.22%31K | -32.69%35K | 329.41%73K | 329.41%73K | 65.52%48K |
| Other current assets | -23.48%678K | -27.68%734K | -60.84%450K | -60.84%450K | -62.07%415K | -24.79%886K | -26.34%1.02M | 17.73%1.15M | 17.73%1.15M | 48.44%1.09M |
| Total current assets | -32.00%5.67M | 103.10%11.98M | -59.53%5.38M | -59.53%5.38M | -89.74%2.22M | -74.01%8.34M | -86.26%5.9M | -76.15%13.29M | -76.15%13.29M | -64.54%21.62M |
| Non current assets | ||||||||||
| Related parties assets | 32.26%41K | ---- | --0 | --0 | -35.42%31K | 72.22%31K | -32.69%35K | 329.41%73K | 329.41%73K | 65.52%48K |
| Total non current assets | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total assets | -32.00%5.67M | 103.10%11.98M | -59.53%5.38M | -59.53%5.38M | -89.74%2.22M | -74.01%8.34M | -86.26%5.9M | -76.15%13.29M | -76.15%13.29M | -64.54%21.62M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 33.39%14.02M | -7.05%14.86M | -26.91%9.39M | -26.91%9.39M | -23.46%10.84M | -23.32%10.51M | 47.06%15.99M | -25.35%12.84M | -25.35%12.84M | 61.84%14.16M |
| -accounts payable | 34.55%10.84M | -15.68%11.92M | -43.04%6.57M | -43.04%6.57M | -39.01%7.96M | -35.96%8.06M | 43.42%14.14M | -28.53%11.54M | -28.53%11.54M | 67.01%13.05M |
| -Due to related parties current | 29.60%3.18M | 58.89%2.94M | 115.54%2.82M | 115.54%2.82M | 159.23%2.88M | 118.04%2.45M | 82.36%1.85M | 22.86%1.31M | 22.86%1.31M | 18.70%1.11M |
| Current accrued expenses | -60.43%6.5M | -1.61%6.8M | 1.88%7.71M | 1.88%7.71M | -6.11%7.42M | 59.22%16.44M | -39.78%6.91M | -4.66%7.57M | -4.66%7.57M | 107.89%7.9M |
| Other current liabilities | -96.84%125K | -96.53%125K | -98.88%125K | -98.88%125K | --1.99M | --3.96M | --3.6M | --11.17M | --11.17M | ---- |
| Current liabilities | -32.24%21.42M | -20.84%22.23M | -43.78%18.43M | -43.78%18.43M | -7.38%21.26M | 28.38%31.61M | 23.73%28.08M | 26.14%32.77M | 26.14%32.77M | 76.58%22.96M |
| Non current liabilities | ||||||||||
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total liabilities | -32.24%21.42M | -20.84%22.23M | -43.78%18.43M | -43.78%18.43M | -7.38%21.26M | 28.38%31.61M | 23.73%28.08M | 26.14%32.77M | 26.14%32.77M | 76.58%22.96M |
| Shareholders'equity | ||||||||||
| Share capital | 100.00%4K | 300.00%4K | 200.00%3K | 200.00%3K | -80.00%2K | -77.78%2K | -88.89%1K | 0.00%1K | 0.00%1K | 11.11%10K |
| -common stock | 100.00%4K | 300.00%4K | 200.00%3K | 200.00%3K | -80.00%2K | -77.78%2K | -88.89%1K | 0.00%1K | 0.00%1K | 11.11%10K |
| Retained earnings | -14.67%-331.95M | -19.17%-325.28M | -19.75%-314.33M | -19.75%-314.33M | -22.26%-295.21M | -25.40%-289.48M | -25.96%-272.96M | -31.33%-262.49M | -31.33%-262.49M | -41.95%-241.46M |
| Paid-in capital | 18.78%316.2M | 24.25%311.61M | 23.54%297.86M | 23.54%297.86M | 15.01%276.16M | 11.71%266.21M | 5.85%250.78M | 8.12%241.12M | 8.12%241.12M | 10.11%240.12M |
| Other equity interest | ---- | --3.42M | 81.38%3.42M | 81.38%3.42M | ---- | ---- | ---- | -71.43%1.89M | -71.43%1.89M | ---- |
| Total stockholders'equity | 32.32%-15.75M | 53.79%-10.25M | 33.03%-13.05M | 33.03%-13.05M | -1,326.44%-19.04M | -411.85%-23.27M | -209.71%-22.18M | -165.50%-19.48M | -165.50%-19.48M | -102.78%-1.34M |
| Total equity | 32.32%-15.75M | 53.79%-10.25M | 33.03%-13.05M | 33.03%-13.05M | -1,326.44%-19.04M | -411.85%-23.27M | -209.71%-22.18M | -165.50%-19.48M | -165.50%-19.48M | -102.78%-1.34M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg